Genetic association of adrenergic receptor alpha 2A with obesity and type 2 diabetes

Obesity

Volumn 21, Issue 8, 2013, Pages 1720-1725

  Långberg, Ewa Carin ^a   Seed Ahmed, Mohammed ^a   Efendic, Suad ^a   Gu, Harvest F ^a   Östenson, Claes Göran ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; MESSENGER RNA;

ADRA2A GENE; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CASE CONTROL STUDY; ETHNIC GROUP; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET CELL; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDISH;

BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, ALPHA-2; RNA, MESSENGER; SWEDEN;

EID: 84883174085     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20162     Document Type: Article

References (40)

1. Bratusch-Marrain PR,. Insulin-counteracting hormones: their impact on glucose metabolism. Diabetologia 1983; 24: 74-79.
2. Efendic̈ S,. Catecholamines and metabolism of human adipose tissue. 3. Comparison between the regulation of lipolysis in omental and subcutaneous adipose tissue. Acta Med Scand 1970; 187: 477-483.
3. Stich V, Pelikanova T, Wohl P, et al. Activation of alpha2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic euglycemic clamp in men. Am J Physiol Endocrinol Metab 2003; 285: E599-E607.
4. Lambert GW, Straznicky NE, Lambert EA, Dixon JB, Schlaich MP,. Sympathetic nervous activation in obesity and the metabolic syndrome-causes, consequences and therapeutic implications. Pharmacol Ther 2010; 126: 159-172.
5. Clement K, Boutin P, Froguel P,. Genetics of obesity. Am J Pharmacogenomics 2002; 2: 177-187.
6. Tentolouris N, Liatis S, Katsilambros N,. Sympathetic system activity in obesity and metabolic syndrome. Ann N Y Acad Sci 2006; 1083: 129-152.
7. Ostenson C, Pigon J, Doxey J, Efendic S,. Alpha 2-adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetes. J Clin Endocrinol Metab 1988; 67: 1054-1059.
8. Devedjian J, Pujol A, Cayla C, et al. Transgenic mice overexpressing alpha2A-adrenoceptors in pancreatic beta-cells show altered regulation of glucose homeostasis. Diabetologia 2000; 43: 899-906.
9. Savontaus E, Fagerholm V, Rahkonen O, Scheinin M,. Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in alpha2A-adrenoceptor knockout mice. Eur J Pharmacol 2008; 578: 359-364.
10. Lima J, Feng H, Duckworth L, et al. Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Metabolism 2007; 56: 757-765.
11. Ukkola O, Pérusse L, Chagnon Y, Després J, Bouchard C,. Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Québec Family Study. Int J Obes Relat Metab Disord 2001; 25: 1332-1339.
12. Rosmond R, Bouchard C, Björntorp P,. A C-1291G polymorphism in the alpha2A-adrenergic receptor gene (ADRA2A) promoter is associated with cortisol escape from dexamethasone and elevated glucose levels. J Intern Med 2002; 251: 252-257.
13. Li J, Canham R, Vongpatanasin W, Leonard D, Auchus R, Victor R,. Do allelic variants in alpha2A and alpha2C adrenergic receptors predispose to hypertension in blacks? Hypertension 2006; 47: 1140-1146.
14. Flordellis C, Manolis A, Scheinin M, Paris H,. Clinical and pharmacological significance of alpha2-adrenoceptor polymorphisms in cardiovascular diseases. Int J Cardiol 2004; 97: 367-372.
15. 2A-adrenergic receptors contributes to Type 2 Diabetes. Science 2010; 327: 217-220.
16. Eriksson AK, Ekbom A, Granath F, Hilding A, Efendic S, Ostenson CG,. Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diab Med 2008; 7: 834-842.
17. Alberti KGMM, Zimmet P,. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab Med 1998; 15: 539-553.
18. National Heart LaBI. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. June 1998.
19. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW,. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413-420.
20. A haplotype map of the human genome. Nature 2005; 437: 1299-1320.
21. Weir BS,. Disequilibrium. Genetic Data Analysis II: Methods for Discrete Population Genetic Data, 2nd. ed. Sunderland, Massachusetts: Sinauer Associates; 1996, pp 91-140.
22. Purcell S, Cherny SS, Sham PC,. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19: 149-150.
23. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R,. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
24. Wolfarth B, Rivera M, Oppert J, et al. A polymorphism in the alpha2a-adrenoceptor gene and endurance athlete status. Med Sci Sports Exerc 2000; 32: 1709-1712.
25. Freeman K, Farrow S, Schmaier A, Freedman R, Schork T, Lockette W,. Genetic polymorphism of the alpha 2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans. Am J Hypertens 1995; 8: 863-869.
26. Michel M, Plogmann C, Philipp T, Brodde O,. Functional correlates of alpha(2A)-adrenoceptor gene polymorphism in the HANE study. Nephrol Dial Transplant 1999; 14: 2657-2663.
27. Belfer I, Buzas B, Hipp H, et al. Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each gene. J Hum Genet 2005; 50: 12-20.
28. Kurnik D, Muszkat M, Li C, et al. Variations in the alpha2A-adrenergic receptor gene and their functional effects. Clin Pharmacol Ther 2006; 79: 173-185.
29. Brodde O, Bock K,. Changes in platelet alpha 2-adrenoceptors in human phaeochromocytoma. Eur J Clin Pharmacol 1984; 26: 265-267.
30. Michel M, Mindermann G, Daul A, Brodde O,. Effects of antihypertensive therapy on human alpha- and beta-adrenoceptors. J Hypertens 1991; 9: 601-606.
31. Luthra A, Borkowski K, Carruthers S,. Genetic aspects of variability in superficial vein responsiveness to norepinephrine. Clin Pharmacol Ther 1991; 49: 355-361.
32. Långberg E, Gu HF, Nordman S, Efendic S, Ostenson CG,. Genetic variation in receptor protein tyrosine phosphatase sigma is associated with type 2 diabetes in Swedish Caucasians. Eur J Endocrinol 2007; 157: 459-464.
33. O'Donnell C, Lindpaintner K, Larson M, et al. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998; 97: 1766-1772.
34. McCarthy J, Meyer J, Moliterno D, Newby L, Rogers W, Topol E,. Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients. Hum Genet 2003; 114: 87-98.
35. Nordman S, Ding B, Ostenson C, et al. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men. Exp Clin Endocrinol Diab 2005; 113: 282-287.
36. Dionne I, Turner A, Tchernof A, et al. Identification of an interactive effect of beta3- and alpha2b-adrenoceptor gene polymorphisms on fat mass in Caucasian women. Diabetes 2001; 50: 91-95.
37. Ukkola O, Rankinen T, Weisnagel S, et al. Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study. Metabolism 2000; 49: 1063-1070.
38. Rosmond R,. Association studies of genetic polymorphisms in central obesity: a critical review. Int J Obes Relat Metab Disord 2003; 27: 1141-1151.
39. Leineweber K, Büscher R, Bruck H, Brodde O,: Beta-adrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol 2004; 369: 1-22.
40. Rankinen T, Zuberi A, Chagnon Y, et al. The human obesity gene map: the 2005 update. Obesity 2006; 14: 529-644.